30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cognition Therapeutics Inc (CGTX)

Track

In the last 90 days, Cognition Therapeutics Inc. saw three executive buy transactions totaling $32,492.5. Notably, the CEO, CFO, and Chief Medical Officer made purchases on April 16, 2026. There were no sell transactions reported during this period. The stock has experienced a 28.3% price increase over the past 90 days.
Stock chart
Ticker: CGTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Doyle John Brendan
Chief Financial Officer
1 purchase — total 11,300 USD
Buy 16 Apr 2026
Value US$2,226,244.69 | Price 189.36 | Shares 51,256
Buy 16 Apr 2026
Value US$1,743,704.00 | Price 302.02 | Shares 89,466
Buy 16 Apr 2026
Value US$11,100.00 | Price 1.11 | Shares 10,000
Buy 31 Jan 2025
Value US$30,000.74 | Price 0.77 | Shares 38,851
Buy 14 Mar 2024
Value US$9,975.00 | Price 1.75 | Shares 5,700
Buy 29 Nov 2022
Value US$26,550.00 | Price 2.66 | Shares 10,000
Buy 28 Nov 2022
Value US$4,957.59 | Price 2.65 | Shares 1,871
Buy 28 Nov 2022
Value US$32,379.33 | Price 2.65 | Shares 12,220
Buy 28 Nov 2022
Value US$5,227.86 | Price 2.65 | Shares 1,973
Buy 28 Nov 2022
Value US$4,957.59 | Price 2.65 | Shares 1,871
Buy 28 Nov 2022
Value US$32,379.33 | Price 2.65 | Shares 12,220
Buy 28 Nov 2022
Value US$5,227.86 | Price 2.65 | Shares 1,973
Buy 16 Nov 2022
Value US$11,576.60 | Price 1.40 | Shares 8,269
Buy 16 Nov 2022
Value US$75,612.60 | Price 1.40 | Shares 54,009
Buy 16 Nov 2022
Value US$12,210.80 | Price 1.40 | Shares 8,722
Buy 16 Nov 2022
Value US$11,576.60 | Price 1.40 | Shares 8,269
Buy 16 Nov 2022
Value US$75,612.60 | Price 1.40 | Shares 54,009
Buy 16 Nov 2022
Value US$12,210.80 | Price 1.40 | Shares 8,722
Buy 15 Nov 2022
Value US$15,600.00 | Price 1.30 | Shares 12,000
Buy 15 Nov 2022
Value US$209,640.00 | Price 1.20 | Shares 174,700
Buy 15 Nov 2022
Value US$1,369,236.00 | Price 1.20 | Shares 1,141,030
Buy 15 Nov 2022
Value US$221,124.00 | Price 1.20 | Shares 184,270
Buy 15 Nov 2022
Value US$209,640.00 | Price 1.20 | Shares 174,700
Buy 15 Nov 2022
Value US$1,369,236.00 | Price 1.20 | Shares 1,141,030
Buy 15 Nov 2022
Value US$221,124.00 | Price 1.20 | Shares 184,270
Buy 15 Nov 2022
Value US$15,000.00 | Price 1.20 | Shares 12,500
Buy 13 Oct 2021
Value US$36,000.00 | Price 12.00 | Shares 3,000
Sale 13 Oct 2021
Value US$888.60 | Price 12.00 | Shares 74
Sale 13 Oct 2021
Value US$397.08 | Price 12.00 | Shares 33
Buy 13 Oct 2021
Value US$1,734,360.00 | Price 12.00 | Shares 144,530
Buy 13 Oct 2021
Value US$265,548.00 | Price 12.00 | Shares 22,129
Sale 13 Oct 2021
Value US$1,083.36 | Price 12.00 | Shares 90
Buy 13 Oct 2021
Value US$280,092.00 | Price 12.00 | Shares 23,341
Sale 13 Oct 2021
Value US$140.88 | Price 12.00 | Shares 12
Buy 13 Oct 2021
Value US$1,734,360.00 | Price 12.00 | Shares 144,530
Buy 13 Oct 2021
Value US$265,548.00 | Price 12.00 | Shares 22,129
Sale 13 Oct 2021
Value US$1,083.36 | Price 12.00 | Shares 90
Buy 13 Oct 2021
Value US$280,092.00 | Price 12.00 | Shares 23,341
Buy 13 Oct 2021
Value US$60,000.00 | Price 12.00 | Shares 5,000
Buy 13 Oct 2021
Value US$150,000.00 | Price 12.00 | Shares 12,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16 B Purchase
Doyle John Brendan

Chief Financial Officer

Officer
51,256 +29.1%
189.36
US$2,226,245 		51,256 +29.1% 189.36 US$2,226,245
2026-04-20 2026-04-16 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
89,466 +30.5%
302.02
US$1,743,704 		89,466 +30.5% 302.02 US$1,743,704
2026-04-20 2026-04-16 B Purchase
Caggiano Anthony

Chief Medical Officer

Officer
92,782 -41.2%
234.54
US$2,186,609 		92,782 -41.2% 234.54 US$2,186,609
2025-02-04 2025-01-31 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
38,851 +inf%
0.77
US$30,001 		38,851 +inf% 0.77 US$30,001
2024-03-14 2024-03-14 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
5,700 +2.0%
1.75
US$9,975 		5,700 +2.0% 1.75 US$9,975
2022-11-29 2022-11-29 B Purchase
1.8
RICHSTONE ELLEN B
Non-Executive Director
10,000 +inf%
2.66
US$26,550 		10,000 +inf% 2.66 US$26,550
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
1,871 +0.6%
2.65
US$4,958 		1,871 +0.6% 2.65 US$4,958
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
12,220 +0.6%
2.65
US$32,379 		12,220 +0.6% 2.65 US$32,379
2022-11-29 2022-11-28 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
1,973 +0.6%
2.65
US$5,228 		1,973 +0.6% 2.65 US$5,228
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
1,871 +0.6%
2.65
US$4,958 		1,871 +0.6% 2.65 US$4,958
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
12,220 +0.6%
2.65
US$32,379 		12,220 +0.6% 2.65 US$32,379
2022-11-29 2022-11-28 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
1,973 +0.6%
2.65
US$5,228 		1,973 +0.6% 2.65 US$5,228
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
8,269 +2.8%
1.40
US$11,577 		8,269 +2.8% 1.40 US$11,577
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
54,009 +2.8%
1.40
US$75,613 		54,009 +2.8% 1.40 US$75,613
2022-11-17 2022-11-16 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
8,722 +2.8%
1.40
US$12,211 		8,722 +2.8% 1.40 US$12,211
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
8,269 +2.8%
1.40
US$11,577 		8,269 +2.8% 1.40 US$11,577
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
54,009 +2.8%
1.40
US$75,613 		54,009 +2.8% 1.40 US$75,613
2022-11-17 2022-11-16 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
8,722 +2.8%
1.40
US$12,211 		8,722 +2.8% 1.40 US$12,211
2022-11-16 2022-11-15 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
12,000 +96.0%
1.30
US$15,600 		12,000 +96.0% 1.30 US$15,600
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
174,700 +139.9%
1.20
US$209,640 		174,700 +139.9% 1.20 US$209,640
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
1,141,030 +140.1%
1.20
US$1,369,236 		1,141,030 +140.1% 1.20 US$1,369,236
2022-11-16 2022-11-15 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
184,270 +139.8%
1.20
US$221,124 		184,270 +139.8% 1.20 US$221,124
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
174,700 +139.9%
1.20
US$209,640 		174,700 +139.9% 1.20 US$209,640
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
1,141,030 +140.1%
1.20
US$1,369,236 		1,141,030 +140.1% 1.20 US$1,369,236
2022-11-16 2022-11-15 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director
184,270 +139.8%
1.20
US$221,124 		184,270 +139.8% 1.20 US$221,124
2022-11-16 2022-11-15 B Purchase
2.0
Wallace Peggy
Non-Executive Director
12,500 +49.1%
1.20
US$15,000 		12,500 +49.1% 1.20 US$15,000
2021-10-25 2021-10-13 B Purchase
2.0
Wallace Peggy
Non-Executive Director
3,000 +inf%
12.00
US$36,000 		3,000 +inf% 12.00 US$36,000
2021-10-15 2021-10-13 S Sale
3.1
Ogden CAP Associates, LLC
Large shareholder
74 -0.0%
12.00
US$889 		74 -0.0% 12.00 US$889
2021-10-15 2021-10-13 S Sale
3.1
Golden Seeds Cognition Therapeutics LLC
Large shareholder
33 -0.0%
12.00
US$397 		33 -0.0% 12.00 US$397
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
144,530 +19.1%
12.00
US$1,734,360 		144,530 +19.1% 12.00 US$1,734,360
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
22,129 +33.6%
12.00
US$265,548 		22,129 +33.6% 12.00 US$265,548
2021-10-15 2021-10-13 S Sale
0.9
BIOS Memory SPV I, LP
Large shareholder
90 -0.0%
12.00
US$1,083 		90 -0.0% 12.00 US$1,083
2021-10-15 2021-10-13 B Purchase
0.9
BIOS Memory SPV I, LP
Large shareholder
23,341 +68.2%
12.00
US$280,092 		23,341 +68.2% 12.00 US$280,092
2021-10-15 2021-10-13 S Sale
3.1
Breedlove Mark H.
Non-Executive Director
12 -0.0%
12.00
US$141 		12 -0.0% 12.00 US$141
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
144,530 +19.1%
12.00
US$1,734,360 		144,530 +19.1% 12.00 US$1,734,360
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
22,129 +33.6%
12.00
US$265,548 		22,129 +33.6% 12.00 US$265,548
2021-10-15 2021-10-13 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director
90 -0.0%
12.00
US$1,083 		90 -0.0% 12.00 US$1,083
2021-10-15 2021-10-13 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
23,341 +68.2%
12.00
US$280,092 		23,341 +68.2% 12.00 US$280,092
2021-10-14 2021-10-13 B Purchase
0.7
O'Brien James Michael

Chief Financial Officer

Officer
5,000 +inf%
12.00
US$60,000 		5,000 +inf% 12.00 US$60,000
2021-10-14 2021-10-13 B Purchase
2.1
Ricciardi Lisa

CEO & President

Executive Director
12,500 +inf%
12.00
US$150,000 		12,500 +inf% 12.00 US$150,000
Explore more

More insider trading research around Cognition Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America